News

Kalfus & Nachman Celebrates a Decade of Community Support

Kalfus & Nachman Celebrates a Decade of Community Support

Kalfus & Nachman Celebrates a Decade of Community Support

Kalfus & Nachman, a prominent personal injury law firm in Hampton Roads, is thrilled to reaffirm its dedication as a Pink Ribbon Sponsor for a significant cause. As they embark on the journey of their 11th consecutive year supporting the Making Strides Against Breast Cancer walk, their commitment resonates through the community, showcasing their long-term partnership with this vital cause.

The firm has proudly contributed over $25,000 to the American Cancer Society throughout the last decade. This funding plays a crucial role in advancing innovative research, providing free patient services and accommodations, and offering essential support programs for individuals currently facing the battle against breast cancer and their families.

Paul R. Hernandez, one of the committed attorneys at Kalfus & Nachman, stated, "For eleven years, our firm has stood alongside survivors, caregivers, and families. Their remarkable strength and resilience are inspiring. Supporting this cause transcends mere contribution; it forms the essence of who we are. We wholeheartedly believe in standing together with our community, and there is no cause more urgent than this one. We are privileged to contribute to the progress that the American Cancer Society achieves every day."

The Making Strides Against Breast Cancer event transcends being just another walk; it transforms into an uplifting occasion that unites the Hampton Roads area. It serves as a platform to honor breast cancer survivors, memorialize those who have succumbed to this illness, and gather vital resources to strive for a future free from breast cancer. The atmosphere is filled with hope, unity, and collective purpose.

The Kalfus & Nachman team, including its attorneys, staff, and their families, is ready to participate in the walk and invites other local businesses and community members to join in this noble endeavor.

Event details are as follows:

Making Strides Against Breast Cancer of the Peninsula

Date: Sunday, October 19

Time: Walk begins promptly at 2:00 PM

Location: Newport News City Park

About Kalfus & Nachman

Kalfus & Nachman has been a steadfast pillar in the Hampton Roads community for over 45 years. With deep roots in personal injury, accident, and disability law, the firm stands apart through its robust commitment to corporate social responsibility. The dedication to giving back is evident through their active involvement in various charitable initiatives, focusing on healthcare, education, and enhancing the well-being of the communities they serve.

About Making Strides Against Breast Cancer

This organization operates the largest network of breast cancer awareness events nationwide, engaging nearly 300 communities in a unifying effort to combat breast cancer. The funds raised assist the American Cancer Society in saving lives by supporting groundbreaking research, ensuring free access to patient resources, and facilitating preventive screenings for all women.

For more information about Kalfus & Nachman and their community efforts, please contact them at 855-880-8163.

Frequently Asked Questions

What is the purpose of the Making Strides walk?

The Making Strides walk aims to raise awareness and funds for breast cancer research, providing support and resources for those affected by the disease.

How long has Kalfus & Nachman been supporting this cause?

Kalfus & Nachman has proudly supported the Making Strides Against Breast Cancer walk for eleven consecutive years.

What kind of contributions has Kalfus & Nachman made over the years?

Over the past decade, the firm has contributed more than $25,000 to the American Cancer Society, supporting vital services for breast cancer patients and their families.

Who is involved in the team for the event?

The Kalfus & Nachman team, including their attorneys and staff along with their families, actively participates in the event, showcasing community solidarity.

How can individuals get involved in the Making Strides event?

Community members and local businesses are encouraged to join the team in the Making Strides walk and contribute to the fight against breast cancer.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Webull Faces Class Action: Key Details for Investors

Updated Category News Views 158

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 153

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 119

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 183

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 244

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 203

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Updated Category News Views 211

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 138

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
HiTHIUM Joins Cambridge to Boost Global Energy Storage

Updated Category News Views 365

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 139

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading

Top 5 Most Recently Viewed Articles

BlueLinx Expands Its Reach with New Portland Distribution Hub

Updated Category News Views 147

BlueLinx Unveils New Distribution Center in Portland BlueLinx Holdings Inc. (NYSE: BXC) has officially opened a greenfield distribution center in Portland, enhancing its operational footprint in the Pacific Northwest. This facility is a significant addition to the company’s distribution capabilities, as it strategically positions BlueLinx to serve the growing demands of...

Continue Reading
IBA Partners with China Gold to Advance X-ray Technological Growth

Updated Category News Views 255

Strategic Partnership for Industry Advancement In a significant move for the irradiation processing industry, IBA (Ion Beam Applications S.A., EURONEXT) has joined forces with China Gold Irradiation (CGI), the premier irradiation service provider in China. This collaboration is set to elevate the standards of irradiation services by incorporating advanced X-ray...

Continue Reading
Amerant Bank and Partners Generate Support for Local Charity

Updated Category News Views 189

Generous Collaboration: Amerant Bank's Community Impact In a heartwarming display of community spirit, Amerant Bank has partnered with Sedano’s Supermarkets and Fresco y Más to make a significant difference in the lives of underserved children and families. The culmination of their efforts was marked by a grand check presentation to Centro Mater, a renowned...

Continue Reading
Mediar Therapeutics Advances Phase 2 Trial for Rare Lung Disease

Updated Category News Views 123

Mediar Therapeutics Initiates Phase 2 WISPer Trial Mediar Therapeutics, Inc., a pioneering clinical-stage biotechnology company, has reached a major milestone by dosing the first patient in its Phase 2 WISPer clinical trial. This trial focuses on evaluating MTX-463, a first-in-class therapy designed to combat idiopathic pulmonary fibrosis (IPF). The primary goal of this...

Continue Reading
Chime Biologics and Waterstone Unite for ADC Innovation

Updated Category News Views 242

Chime Biologics and Waterstone Forge a New Path in ADC Development Chime Biologics and Waterstone Pharmaceuticals have officially announced a strategic partnership designed to enhance the capabilities and efficiencies within the Antibody-Drug Conjugate (ADC) industry. By combining their expertise, both companies aim to provide integrated services that boost the...

Continue Reading